| ²é¿´: 1360 | »Ø¸´: 3 | |||
maximus86Òø³æ (СÓÐÃûÆø)
|
[ÇóÖú]
Ò©¼Á·½ÃæµÄÎÄÕÂͶÄĸöÔÓÖ¾ºÃÖÐ
|
|
×î½üдһÁËÆª¹ØÓÚijһ¸öÒ©ÎïÖÆ¼ÁÑо¿µÄÓ¢ÎÄÎÄÕ£¬Í¨¹ý´óÊóʵÑ鿼²ìµÄ£¬Çë½Ì´ó¼ÒʲôͶʲôÔÓÖ¾ºÃÖÐЩ£¬ÒªÇ󲻸ߣ¬IF1~2¾Í¿ÉÒÔ£¬µ«ÊDz»ÄÜÓаæÃæ·ÑÓ´£¬ÓоÑéµÄ·ÖÏíÏ£¬Ð»Ð»Ð»Ð»´ó¼ÒÁË ÁíÍ⣬ÎÒ²éÁËһϣ¬Drug Development Research£¬Õâ¸öÔÓÖ¾ÔõôÑù£¬ÓÐûÓÐͶ¹ýµÄÅóÓÑ£¬Éó¸åËٶȺÍÃüÖÐÂÊÈçºÎ£¬ÊÕ²»ÊÕ·ÑÁ¨£¿ |
» ÊÕ¼±¾ÌûµÄÌÔÌûר¼ÍƼö
ËæÔµ |
» ²ÂÄãϲ»¶
µ÷¼Á
ÒѾÓÐ6È˻ظ´
Ò»Ö¾Ô¸ ½ÄÏ´óѧ 085602 »¯¹¤×¨Ë¶ 338·ÖÇóµ÷¼Á
ÒѾÓÐ12È˻ظ´
²ÄÁÏר˶(0856) 339·ÖÇóµ÷¼Á
ÒѾÓÐ8È˻ظ´
377Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
0703µ÷¼Á£¬Ò»Ö¾Ô¸Ìì½ò´óѧ319·Ö
ÒѾÓÐ6È˻ظ´
Ò»Ö¾Ô¸Äϲý´óѧ£¬085600£¬344·ÖÇóµ÷¼Á
ÒѾÓÐ5È˻ظ´
308Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
ÕÒµ÷¼Á
ÒѾÓÐ9È˻ظ´
Ò»Ö¾Ô¸Ö£ÖÝ´óѧ085600Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
316Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
×ÛÊöÀàÎÄÕÂͶÄĸöÔÓÖ¾±È½ÏºÃ£¿
ÒѾÓÐ3È˻ظ´
»·¾³²ÄÁÏÀàÎÄÕ·¢SCIͶÄĸöÔÓÖ¾ºÃ
ÒѾÓÐ7È˻ظ´
¶¯ÎﲡÔ΢ÉúÎïÉúÎﱻĤ·½ÃæµÄÎÄÕÂÍùÄĸöSCIÔÓ־Ͷ¸å½ÏºÃ°¡£¿
ÒѾÓÐ3È˻ظ´
ͶʳƷ°²È«¼ì²â·½ÃæµÄÖÐÎÄÎÄÕÂÓÐʲôºÃµÄÔÓÖ¾£¬×îºÃÊÇEIµÄ
ÒѾÓÐ10È˻ظ´
Ó¦ÓÃÐÍÎÄÕÂͶʲôÆÚ¿¯ÔÓÖ¾±È½ÏºÃ
ÒѾÓÐ12È˻ظ´
дÁËһƪʳƷ¹¤ÒÕ·½ÃæµÄÓ¢ÎÄÎÄÕ£¬Çó½ÏºÃµÄÍâÎÄÔÓÖ¾
ÒѾÓÐ8È˻ظ´
¹úÄÚÒ©¼ÁÔÓÖ¾ÄÇЩ±È½ÏºÃŶ
ÒѾÓÐ8È˻ظ´
±¾ÈËÓÐÆªÎÄÕ²»ÖªÍ¶Ê²Ã´ºÃ£¬Çó´ó¼Ò½éÉÜһϴ߻¯ÀàµÄÔÓÖ¾
ÒѾÓÐ22È˻ظ´
ÇóÍÆ¼öÒªÇóµÍµÄºËÐÄÆÚ¿¯£¬¼±ÓÚ·¢±íÎÄÕÂ
ÒѾÓÐ13È˻ظ´
ʳƷ»¯Ñ§·½ÃæµÄÓ¢ÎÄÎÄÕÂÄĸöÔÓÖ¾ÈÝÒ×½ÓÊÕ
ÒѾÓÐ13È˻ظ´
¡¶Öйú»úе¹¤³Ì¡·ÔÓÖ¾ÓÐÄÄλͶ¹ý°¡£¿±ÏÒµ·¢ÎÄÕÂÇóÖú
ÒѾÓÐ23È˻ظ´
ÇóÖúºÏÊÊ·¢±íµÄÒ©¼ÁѧӢÎÄÔÓÖ¾
ÒѾÓÐ4È˻ظ´
ÎÄÕÂͶÄĸöÔÓÖ¾±È½Ï¿¿Æ×£¿
ÒѾÓÐ4È˻ظ´
ÓйØÏ¡ÍÁ·¢¹â²£Á§·½ÃæÎÄÕ²»ÖªµÀͶÄĸöÔÓÖ¾ºÃ
ÒѾÓÐ8È˻ظ´
Çë½Ìһϸ÷λ´óϺ£¬Í¶ÖÐÎÄÒ©¼Á·½ÃæµÄÔÓÖ¾£¬Òª¿ìÒ»µã½ÓÊܵ쬶¼¿ÉÒÔͶÄÄЩ
ÒѾÓÐ12È˻ظ´
Ò©¼Á·½ÏòSCIͶ¸åÔÓ־ѡÔñ£¬Çë¸÷λǰ±²Ö¸µãÃÔ½ò£¡
ÒѾÓÐ13È˻ظ´
¸¾²ú¿ÆÉúÖ³·½ÃæµÄÎÄÕºÍ×ÛÊöÍù¸¾²ú¿ÆµÄÄĸöÔÓ־ͶºÃ°¡
ÒѾÓÐ4È˻ظ´
ÓÐûÓк÷¢µÄÓ¢ÎÄÒ©¼ÁÆÚ¿¯£¿
ÒѾÓÐ11È˻ظ´
ͬÀàÎÄÕ£¬Í¶Í¬Ò»¸öÔÓÖ¾£¬²»Í¬µÄ½á¹û
ÒѾÓÐ19È˻ظ´
Ò©¼Á·½Ãæ±È½ÏºÃµÄÔÓÖ¾
ÒѾÓÐ3È˻ظ´
¡¾ÇóÖú¡¿Î¢ÉúÎï»ùÒò¿Ë¡·½ÃæµÄÎÄÕÂÄÜ·¢ÄĸöSCIÔÓÖ¾
ÒѾÓÐ23È˻ظ´
´ó·Ö×Ó×Ô×é×°·½ÃæÄ£ÄâÀàÎÄÕÂͶÄĸöÔÓÖ¾±È½Ï¿ì£¿
ÒѾÓÐ9È˻ظ´
ÓйØPLA½á¾§ÒÔ¼°Á¦Ñ§ÐÔÄÜÑо¿µÄÎÄÕÂͶʲôÔÓÖ¾±È½ÏºÃ£¿
ÒѾÓÐ5È˻ظ´
ÌÕ´ÉÀàµÄÎÄÕÂͶÄĸöÔÓÖ¾
ÒѾÓÐ11È˻ظ´
СС10-3
ľ³æ (СÓÐÃûÆø)
- Ó¦Öú: 3 (Ó×¶ùÔ°)
- ½ð±Ò: 1675.3
- ºì»¨: 1
- Ìû×Ó: 215
- ÔÚÏß: 134.3Сʱ
- ³æºÅ: 810666
- ×¢²á: 2009-07-17
- ÐÔ±ð: GG
- רҵ: Ò©¼Áѧ
2Â¥2013-05-11 19:13:38
zhenwuhuang
ÖÁ×ðľ³æ (ÎÄѧ̩¶·)
- Ó¦Öú: 4351 (¸±½ÌÊÚ)
- ½ð±Ò: 10162.3
- É¢½ð: 1
- ºì»¨: 137
- Ìû×Ó: 65928
- ÔÚÏß: 2434.8Сʱ
- ³æºÅ: 2227382
- ×¢²á: 2013-01-07
- ÐÔ±ð: GG
- רҵ: ÈËÀàÓªÑø
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
maximus86: ½ð±Ò+7, ¡ïÓаïÖú 2013-05-12 10:30:29
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
maximus86: ½ð±Ò+7, ¡ïÓаïÖú 2013-05-12 10:30:29
3Â¥2013-05-11 19:39:51
zhenwuhuang
ÖÁ×ðľ³æ (ÎÄѧ̩¶·)
- Ó¦Öú: 4351 (¸±½ÌÊÚ)
- ½ð±Ò: 10162.3
- É¢½ð: 1
- ºì»¨: 137
- Ìû×Ó: 65928
- ÔÚÏß: 2434.8Сʱ
- ³æºÅ: 2227382
- ×¢²á: 2013-01-07
- ÐÔ±ð: GG
- רҵ: ÈËÀàÓªÑø
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï
maximus86: ½ð±Ò+1 2013-05-12 10:30:38
maximus86: ½ð±Ò+1 2013-05-12 10:30:38
|
×ÛÊö·½ÃæADV DRUG DELIVER REV ¼ÌÐøÁì¾ü£¬Í»ÆÆ8£¬ ÓÈÆäÖµµÃÒ»ÌáµÄÊÇ£¬Ò©¼ÁÁìÓòÖÕÓÚÒ²ÓпÉÒÔÈÃÎÒÃÇÑïüÍÂÆøµÄ·Ç×ÛÊöÆÚ¿¯ÁË£¬²»À¢ÊÇACS£¬ÆäËùÊôµÄMOL PHARM Ò»±»SCIÊÕ¼¾Í´´ÏÂ11.030µÄ¸ßIF£¬ÆäÖ÷±àºÃÏñÈ¥Ä껹Ôì·ÃÕã½´óѧҩѧԺ¡£ÁíÍ⣬AAPS J ÉÏÉýÉñËÙÓÉÈ¥ÄêµÄ1.874Ò»Ô¾µ½ÏÖÔÚµÄ3.756£¬Õâ¿ÉÄÜÓëÕâ¸öµÄÆÚ¿¯µÄopen accessÓйأ¬µ¼ÖÂÆäpaper¸ßÒýÓ᣶ø´«Í³ÒâÒåÉϵÄÒ©¼ÁÀÏ´óJ CONTROL RELEASE 4.756Ò²²»´í£¬µ«¸Ð¾õ½øÕ¹ËÙ¶ÈÒ»°ã¡£PHARM RES ÉÏÉýѸËÙ£¬ÒÑ¾Í»ÆÆ3´ïµ½3.441£¬ ÁíÍâÆäËû2ÒÔÉÏµÄÆÚ¿¯»¹ÓУºEUR J PHARM SCI £¨3.127£©£¬J PHARM SCI-US £¨2.942£©£¬EUR J PHARM ***£¨2.611£¬Ö»ÓÐÕâ¸öÆÚ¿¯ÔÚÈ¥ÄêÍ»ÆÆ3ºó½ñÄêÓÖ½µ»Ø2£©£¬INT J PHARM £¨2.408£©£¬J DRUG TARGET £¨2.030£¬ÎÒÃÇ×ö°ÐÏòÒ©ÎïµÄÔ´Í·ÆÚ¿¯Å¶£¬Í»ÆÆ2£©£¬J LIPOSOME RES £¨2.021£¬¼¸ºõÉÏÉýÁË1¸öÒò×Ó£¬×ã¼ûÏÖÔÚ´ó¼Ò¶à¹ØÐÄÖ¬ÖÊÌå°¡£©¡£ ˵¾äרҵÍâµÄ»°£¬¿´µ½ÎÒÃÇÖйúÈË×Ô¼º°ìµÄÆÚ¿¯¡¶Cell Research¡·£¨ÓÉÖпÆÔºÉϺ£Éú¿ÆÔºÖ÷°ì£©ÄÜ´ïµ½4.217£¬ÔõôҲҪ¶¥Ò»¸ö£¡ |
4Â¥2013-05-11 19:41:16














»Ø¸´´ËÂ¥